Document is current
Any future updates will be listed below
-
Authors
Agostinho, Alexandra S
Mietzsch, Mario
Zangrandi, Luca
Kmiec, Iwona
Mutti, Anna
Kraus, Larissa
Fidzinski, Pawel
Schneider, Ulf C
Holtkamp, Martin
Heilbronn, Regine https://orcid.org/0000-0001-6412-3278
Schwarzer, Christoph https://orcid.org/0000-0002-6373-3717
-
Funding
Funding for this research was provided by:
Stiftung Charité Berlin (INV_PRO_452)
Austrian Science Fund (I‐977)
Austrian Science Fund (P‐30592)
Austrian Science Fund (W‐1206)
German Research Foundation (DFG He1598/9‐1)
- License Information
-
More Information
Article History
Received: 20 October 2018
Revised: 1 August 2019
Accepted: 6 August 2019
First Online: 5 September 2019
Conflict of interest
: A PCT application of the described technology is pending. R.H. is inventor of a patent related to rAAV technology and owns equity in a company commercializing AAV for gene therapy.
